cysteine and cyclin d1

cysteine has been researched along with cyclin d1 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's4 (50.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Aw, TY; Fujimoto, K; Iwakiri, R; Noda, T; Rhoads, CA1
Gabbert, HE; Geddert, H; Kiel, S; Sarbia, M; Willers, R; Zhang, J; Zotz, RB1
Belame, A; Burow, ME; Carrier, L; Li, Z; Rowan, BG; Salvo, VA; Thiyagarajah, A1
Aggarwal, BB; Chaturvedi, MM; Gupta, SC; Hema, PS; Kannappan, R; Nair, M; Prasad, S; Ravindran, J; Reuter, S; Yadav, VR1
Chiang, EP; Kuo, YH; Pai, MH; Tang, FY1
Amerik, AY; Issaenko, OA1
Aranda, E; Cañas, A; De La Haba-Rodríguez, JR; Fuentes, E; Hernández, V; López-Pedrera, C; López-Sánchez, LM; Muñoz-Castañeda, JR; Rodríguez-Ariza, A; Valverde-Estepa, A1
Beilfuss, N; Puts, R; Raum, K; Zabarylo, U; Zhang, H1

Other Studies

8 other study(ies) available for cysteine and cyclin d1

ArticleYear
Exogenous cysteine and cystine promote cell proliferation in CaCo-2 cells.
    Cell proliferation, 2002, Volume: 35, Issue:2

    Topics: Antimetabolites; Blotting, Western; Buthionine Sulfoximine; Caco-2 Cells; Chromatography, High Pressure Liquid; Cyclin D1; Cysteine; Cystine; Flow Cytometry; G1 Phase; Glutathione; Glutathione Disulfide; Humans; Phosphorylation; Retinoblastoma Protein; S Phase

2002
Polymorphism of p16 INK4A and cyclin D1 in adenocarcinomas of the upper gastrointestinal tract.
    Journal of cancer research and clinical oncology, 2005, Volume: 131, Issue:12

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Alanine; Barrett Esophagus; Cardia; Case-Control Studies; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Cysteine; DNA, Neoplasm; Esophageal Neoplasms; Female; Gene Frequency; Glycine; Homozygote; Humans; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Polymorphism, Single-Stranded Conformational; Stomach Neoplasms

2005
Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis.
    Breast cancer research and treatment, 2009, Volume: 118, Issue:1

    Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Division; Cyclin D1; Cysteine; Drug Synergism; Estradiol; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neovascularization, Pathologic; Organoselenium Compounds; Random Allocation; Receptors, Progesterone; Selenocysteine; Specific Pathogen-Free Organisms; Tamoxifen; Xenograft Model Antitumor Assays

2009
Modification of cysteine 179 of IkappaBalpha kinase by nimbolide leads to down-regulation of NF-kappaB-regulated cell survival and proliferative proteins and sensitization of tumor cells to chemotherapeutic agents.
    The Journal of biological chemistry, 2010, Nov-12, Volume: 285, Issue:46

    Topics: Amino Acid Substitution; Apoptosis; Azadirachta; Blotting, Western; Caspases; Cell Proliferation; Cell Survival; Cyclin D1; Cysteine; Dose-Response Relationship, Drug; Down-Regulation; HEK293 Cells; HL-60 Cells; Humans; I-kappa B Kinase; Jurkat Cells; K562 Cells; Limonins; Molecular Structure; Neoplasms; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Tumor Necrosis Factor-alpha; U937 Cells; Vascular Endothelial Growth Factor A

2010
S-Allylcysteine inhibits tumour progression and the epithelial-mesenchymal transition in a mouse xenograft model of oral cancer.
    The British journal of nutrition, 2012, Jul-14, Volume: 108, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cyclin D1; Cysteine; Epithelial Cells; Fluorescent Antibody Technique, Direct; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Experimental; NF-kappa B; Osteopontin; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Staining and Labeling

2012
Chalcone-based small-molecule inhibitors attenuate malignant phenotype via targeting deubiquitinating enzymes.
    Cell cycle (Georgetown, Tex.), 2012, 05-01, Volume: 11, Issue:9

    Topics: Antineoplastic Agents; Apoptosis; Benzylidene Compounds; Boronic Acids; Bortezomib; Breast Neoplasms; Catalytic Domain; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Chalcone; Cyclin D1; Cysteine; Dose-Response Relationship, Drug; Endopeptidases; Female; HeLa Cells; Humans; Ovarian Neoplasms; Phenotype; Piperidones; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines; Tumor Suppressor Protein p53; Ubiquitin Thiolesterase; Ubiquitins

2012
Maintenance of S-nitrosothiol homeostasis plays an important role in growth suppression of estrogen receptor-positive breast tumors.
    Breast cancer research : BCR, 2012, Dec-05, Volume: 14, Issue:6

    Topics: Antineoplastic Agents, Hormonal; Antirheumatic Agents; Auranofin; Benzothiazoles; Breast Neoplasms; CD24 Antigen; Cell Proliferation; Cell Survival; Cyclin D1; Cysteine; Estradiol; Estrogen Receptor alpha; Extracellular Signal-Regulated MAP Kinases; Female; Fulvestrant; Homeostasis; Humans; Hyaluronan Receptors; MCF-7 Cells; Phosphorylation; Proto-Oncogene Proteins c-akt; RNA Interference; RNA, Messenger; RNA, Small Interfering; S-Nitrosothiols; Spheroids, Cellular; Thioredoxin-Disulfide Reductase; Toluene; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2012
A Tissue Engineering Acoustophoretic (TEA) Set-up for the Enhanced Osteogenic Differentiation of Murine Mesenchymal Stromal Cells (mMSCs).
    International journal of molecular sciences, 2022, Sep-29, Volume: 23, Issue:19

    Topics: Animals; Cell Differentiation; Cells, Cultured; Collagen Type I; Core Binding Factor Alpha 1 Subunit; Cyclin D1; Cysteine; Fibrin; Humans; Hydrogels; Mesenchymal Stem Cells; Mice; Osteocalcin; Osteogenesis; Osteonectin; Osteopontin; Tissue Engineering; Tissue Scaffolds

2022